Article (Published version) (560 Kb) - 
Limited access to UNIGEOther version: http://rms.medhyg.ch/numero-358-page-1961.htm
Highlights
More informations
Scientific Article
unige:31993 
 |
Faut-il doser le BNP chez les patients avec BPCO |
|
| Authors | ||
| Published in | Revue médicale suisse. 2012, vol. 8, no. 358, p. 1961-5 | |
| Abstract | The dosage of natriuretic peptides improves diagnostic performance in patients with acute dyspnea when combined with clinical elements. The high sensitivity of this test allows reasonably excluding heart failure when the value is normal. Nevertheless, an increased level of this biomarker is not specific of heart failure and can be observed in different pathologies such as renal failure, sepsis or elevated pulmonary arterial pressure. We therefore analyse the diagnostic performance of natriuretic peptide in COPD patients and discuss its use for the detection of heart failure in this population. | |
| Keywords | Biological Markers/blood — Dyspnea/complications — Heart Failure/diagnosis — Humans — Natriuretic Peptide, Brain/blood — Pulmonary Disease, Chronic Obstructive/blood | |
| Identifiers | PMID: 23198649 | |
| Full text |
Article (Published version) (560 Kb) - Limited access to UNIGE Other version: http://rms.medhyg.ch/numero-358-page-1961.htm |
|
| Structures | ||
| Citation (ISO format) | GARIANI, Karim, PERRIER, Arnaud, MARTI, Christophe Alberic. Faut-il doser le BNP chez les patients avec BPCO. In: Revue médicale suisse, 2012, vol. 8, n° 358, p. 1961-5. https://archive-ouverte.unige.ch/unige:31993 |
221 hits 
1 download 
Contact an author
Update